Sbc Medical Group Holdings INC 8-K filings

SBC Medical Group Holdings announced a significant reacceleration in growth for Q2 2026, with revenue up 13% and net income soaring 335% year-over-year.

SBC Medical Group Holdings Incorporated is addressing Nasdaq's independent director and audit committee requirements following a board member's departure, with a cure period until July 2027.

SBC Medical Group Holdings Incorporated announces director departure and board size reduction, with plans to appoint a new independent director.

SBC Medical Group Holdings reported a 9% year-over-year revenue decrease to $43 million for Q1 2026, attributed to a franchise fee structure revision, while net income fell 47% to $11 million.

SBC Medical Group Holdings Incorporated announced its fourth quarter and full year 2025 financial results, showing significant net income growth despite revenue declines due to strategic restructuring.

SBC Medical Group Holdings Incorporated announced a strategic minority equity investment in U.S. MedSpa chain OrangeTwist, marking its formal entry into the U.S. medical aesthetics market.

SBC Medical Group Holdings Incorporated announced an updated capital strategy, including a $20 million share repurchase program and the effectiveness of a $50 million Form S-3 shelf registration statement.

SBC Medical Group Holdings announced the final results of its tender offer for Waqoo, Inc. shares, securing a majority ownership stake.

SBC Medical Group Holdings reported a significant 353% increase in Q3 2025 net income to $13 million, despite an 18% year-over-year revenue decrease to $43 million, driven by business restructuring and cost optimization.

SBC Medical Group Holdings Incorporated announced a tender offer for up to 575,000 shares of Waqoo, Inc. and an off-market acquisition of 989,802 shares from its CEO, aiming to make Waqoo a consolidated subsidiary.

SBC Medical Group Holdings reported an 18% year-over-year revenue decrease to $43 million in Q2 2025, attributing the decline to strategic business divestitures and fee structure revisions.

A global aesthetic clinic services provider has acquired a Japanese management support firm, integrating a network of clinics to diversify its portfolio and strengthen its market position.

SBC Medical Group Holdings Incorporated has been added to the Russell 3000 Index, effective June 30, 2025, as part of the annual reconstitution.

SBC Medical Group Holdings Incorporated announced that its stockholders approved a significant amendment to its certificate of incorporation to declassify its board of directors, transitioning to annual director elections starting from the 2026 annual meeting.

SBC Medical Group reported a revenue decrease of 14% year-over-year for Q1 2025 but announced a share repurchase program and is reviewing the acquisition of Risenet Co., Ltd.

SBC Medical Group Holdings Incorporated announces Miki Shimizu will become Chief Strategy Officer, replacing Akira Komatsu, effective April 10, 2025.

SBC Medical Group Holdings reports a decrease in Q4 revenue and income but an increase in full-year revenue and income, highlighting market leadership amidst industry challenges.

SBC Medical Group Holdings announces a strategic decision to purchase Bitcoin equivalent to 1 billion yen as part of its financial strategy.

SBC Medical Group Holdings Incorporated has agreed to sell its ski resort and pilot training subsidiaries to entities owned by its CEO, Dr. Yoshiyuki Aikawa, to focus on its core medical business.

SBC Medical Group Holdings Inc. announced a 23% year-over-year increase in total revenue for the nine months ended September 30, 2024, alongside a 60% increase in net income for the same period.

SBC Medical Group Holdings has finalized its merger with Pono Capital Two and will commence trading on the Nasdaq under the ticker symbol SBC on September 18, 2024.

Pono Capital Two, Inc. stockholders have approved the merger with SBC Medical Group Holdings Incorporated, paving the way for the business combination to close in the coming days.

Pono Capital Two reports on a non-redemption agreement resulting in the purchase of 1,512,575 shares and provides an update on redemption requests ahead of a key shareholder vote.

Pono Capital Two has amended its non-redemption agreement to extend the deadline for its business combination with SBC Medical Group to September 16, 2024.

Pono Capital Two, Inc. has received notices from Nasdaq for failing to meet minimum market value, total holders, and public share requirements, placing its listing status at risk.

Pono Capital Two, Inc. has extended the deadline for its merger with SBC Medical Group Holdings Incorporated to September 30, 2024, via a fourth amendment to their merger agreement.

Pono Capital Two, Inc. received a notice from Nasdaq stating they do not meet the minimum requirement for publicly held shares, putting their listing at risk.

Pono Capital Two, Inc. has increased the principal amount of a convertible promissory note to SBC Medical Group Holdings Incorporated by $1.7 million, amending their previous agreement and releasing claims related to the merger agreement.

Pono Capital Two, Inc. successfully extended its deadline to complete a business combination to November 9, 2024, after a shareholder vote on February 5, 2024.

Pono Capital Two, Inc. has entered into a non-redemption agreement with an unaffiliated investor and is seeking a shareholder vote to extend the deadline for its business combination with SBC Medical Group Holdings Incorporated.